Paul Poirier | Precision Medicine | Best Researcher Award

Published on by Scientist Day

Global Scientist Day Awards

Paul Poirier
Quebec University Institute of Cardiology and Pulmonology

Paul Poirier
Affiliation Quebec University Institute of Cardiology and Pulmonology
Country Canada
Scopus ID 7006516211
Documents 473
Citations 35,166
h-index 74
Subject Area Precision Medicine
Event Global Scientist Day Awards
ORCID 0000-0002-5395-3273

Paul Poirier is a Canadian physician-scientist whose academic career has been dedicated to advancing cardiovascular medicine, obesity research, metabolic health, preventive cardiology, and precision medicine. Through extensive clinical investigation, interdisciplinary collaboration, and evidence-based practice, he has contributed substantially to understanding the interactions between cardiovascular disease, diabetes, obesity, and lifestyle interventions. His scholarly productivity and international recognition have established him as an influential researcher in cardiovascular sciences.[1]

Abstract

Paul Poirier’s research portfolio integrates clinical cardiology with precision medicine by investigating cardiovascular risk factors associated with obesity, diabetes, metabolic syndrome, exercise physiology, and preventive healthcare. His publications have significantly contributed to clinical guidelines and multidisciplinary patient management while supporting personalized therapeutic strategies across cardiovascular medicine.[1]

Keywords

Precision Medicine, Preventive Cardiology, Obesity, Cardiovascular Disease, Exercise Physiology, Diabetes, Metabolic Syndrome, Lifestyle Medicine, Clinical Research, Cardiometabolic Health.

Introduction

The increasing prevalence of obesity and metabolic disorders has emphasized the importance of precision medicine approaches in cardiovascular healthcare. Paul Poirier has played an active role in addressing these challenges through research focusing on individualized risk assessment, lifestyle modification, and evidence-based cardiovascular prevention. His work has strengthened the scientific understanding of cardiometabolic interactions and clinical management strategies.[2]

Research Profile

With more than 470 indexed scientific publications, over 35,000 citations, and an h-index of 74, Paul Poirier has established an internationally recognized research profile. His investigations encompass cardiovascular physiology, obesity medicine, diabetes management, preventive cardiology, clinical epidemiology, and precision healthcare. He has collaborated with numerous international institutions and contributed to major scientific consensus documents and clinical recommendations.[1]

Research Impact

The scientific influence of Paul Poirier is reflected through extensive citations, sustained publication output, international collaborations, and contributions to clinical practice recommendations. His work has enhanced evidence-based cardiovascular prevention and informed healthcare professionals regarding obesity-associated cardiovascular risk and precision therapeutic interventions.[3]

Award Suitability

Paul Poirier demonstrates characteristics associated with distinguished scientific achievement through sustained publication productivity, extensive scholarly influence, international collaboration, and meaningful contributions to cardiovascular medicine and precision healthcare. His research aligns with the objectives of the Global Scientist Day Awards by promoting scientific excellence, clinical innovation, and measurable improvements in patient care and public health.[1]

Conclusion

Paul Poirier has developed an internationally respected academic profile through impactful research in cardiovascular medicine, obesity, metabolic health, and precision medicine. His sustained scientific contributions continue to influence clinical practice, research collaborations, and evidence-based healthcare, making his work highly relevant within the international scientific community.

References

  1. Elsevier (2026). Scopus author details: Paul Poirier, Author ID 7006516211. Scopus.
    https://www.scopus.com/pages/authors/7006516211
  2. Pre-exercise meal macronutrient composition and acute inflammatory response in males with type 2 diabetes mellitus.
    https://doi.org/10.1161/CIRCULATIONAHA.106.171016
  3. ORCID (2026). Paul Poirier ORCID Profile.
    https://orcid.org/0000-0002-5395-3273

Sallysamir Zahran | Drug Development | Best Researcher Award

Published on by Scientist Day

Global Scientist Day Awards

Sallysamir Zahran
Affiliation Egyptian Atomic Energy Authority
Country Egypt
Scopus ID 56490517500
Documents 5
Citations 116
h-index 3
Subject Area Drug Development
Event Global Scientist Day Awards

Sallysamir Zahran

Institution: Egyptian Atomic Energy Authority
Country: Egypt

Sallysamir Zahran is associated with the Egyptian Atomic Energy Authority and contributes to scientific research in the interdisciplinary field of drug development. Research activities have focused on developing innovative pharmaceutical and biomedical solutions supported by experimental investigations and collaborative scientific approaches. Scholarly publications indexed in Scopus demonstrate sustained academic engagement and measurable citation impact within the international research community.[1]

Abstract

Drug development requires integration of pharmaceutical science, biomedical research, analytical methodologies, and translational innovation. Sallysamir Zahran’s scholarly work contributes to these objectives through research that supports improved therapeutic strategies and scientific understanding. The publication record indexed by Scopus reflects consistent scientific productivity, while citation metrics indicate that the research has been referenced by fellow investigators within related disciplines.[1]

Keywords

Drug Development, Pharmaceutical Sciences, Biomedical Research, Therapeutic Innovation, Drug Discovery, Translational Medicine, Experimental Pharmacology, Clinical Research, Medical Science, Scientific Publications

Introduction

Modern drug development combines chemistry, biology, pharmacology, toxicology, and clinical science to produce safe and effective therapeutic interventions. Researchers working within this multidisciplinary environment contribute to improving healthcare outcomes through systematic experimentation, validation, and scientific communication. Publications indexed by international databases such as Scopus provide evidence of research visibility and scholarly dissemination.[1]

Research Profile

Sallysamir Zahran is affiliated with the Egyptian Atomic Energy Authority and has established an academic profile within the field of drug development. According to the available Scopus author profile, the researcher has produced five indexed scholarly documents, accumulated 116 citations, and attained an h-index of 3. These indicators demonstrate measurable scientific engagement and continued participation in internationally indexed research activities.[1]

Research Contributions

The research contributions emphasize experimental investigations supporting pharmaceutical innovation and biomedical applications. Published studies contribute to scientific knowledge related to therapeutic development, laboratory evaluation, and evidence-based research methodologies. Collaborative investigations further strengthen interdisciplinary knowledge exchange while encouraging reproducibility and scientific transparency.[2]

Publications

Research publications indexed within Scopus demonstrate scholarly dissemination in drug development and associated biomedical sciences. These publications collectively contribute to scientific literature through experimental evidence and peer-reviewed communication. Representative research articles include publications with Digital Object Identifiers (DOIs), enabling persistent scholarly access.[2]

Research Impact

Citation-based indicators provide evidence that the published research has received attention from the broader scientific community. The available Scopus metrics indicate 116 citations across five indexed documents with an h-index of 3, reflecting measurable academic influence and continued relevance within drug development research.[1]

Award Suitability

Based on the available scholarly indicators, Sallysamir Zahran demonstrates characteristics commonly associated with academic recognition, including peer-reviewed publications, international indexing, measurable citation performance, and contributions to drug development research. The research portfolio aligns with the objectives of the Global Scientist Day Awards, which recognize scientific excellence, innovation, and continued advancement of research across diverse disciplines.[3]

Conclusion

Sallysamir Zahran has established a recognized research profile within the field of drug development through scholarly publications, citation impact, and international indexing. The documented research activities contribute to scientific knowledge while supporting continued innovation in pharmaceutical and biomedical sciences. The available academic record reflects meaningful participation in global research and represents a profile suitable for consideration within international scientific recognition programs.[1]

References

  1. Elsevier. (2026). Scopus Author Details: Sallysamir Zahran, Author ID 56490517500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56490517500
  2. Novel pyrrole-sulfonamide derivatives as EGFR inhibitors and radiosensitizers in lung cancer.
    http://10.1016/j.bioorg.2025.109173
  3. Global Scientist Day Awards. (2026). Official Award Website.
    https://scientistday.org/

Taeyoung Kyong | Medical Discoveries | Research Excellence Award

Published on by Scientist Day

Prof. Taeyoung Kyong | Medical Discoveries | Research Excellence Award

Yonsei University College of Medicine | South Korea

Professor Taeyoung Kyong is a distinguished hospitalist and academic at Yonsei University College of Medicine, specializing in internal medicine and diabetes care. His work focuses on hospitalist-led care models that enhance glycemic control, patient safety, and care transitions in inpatient settings. He has led and contributed to impactful clinical research, published extensively in indexed journals, and served as a reviewer for international medical journals. Through collaborations with leading hospitals and medical technology firms, he integrates digital health and AI-driven monitoring into clinical practice, advancing evidence-based hospital medicine and improving outcomes for patients with chronic diseases.
View Orcid Profile

Featured Publications

Rolf Teschke | Precision Medicine | Best Academic Researcher Award

Published on by Scientist Day

Prof. Rolf Teschke | Precision Medicine | Best Academic Researcher Award

Prof. Rolf Teschke | Klinikum Hanau | Germany

Rolf Teschke, M.D., Professor of Medicine, is a distinguished German physician and internationally recognized expert in gastroenterology, hepatology, and the complex mechanisms of hepatotoxicity. Born in Gera, he pursued medical studies at the universities of Munich and Marburg, earning his medical degree and completing his inaugural thesis. His early scientific foundation was shaped in pathology, where his interest in liver injury and toxic mechanisms first took root. A pivotal stage of his career unfolded in New York, where he worked under the mentorship of renowned liver specialist Charles S. Lieber. During this period, he conducted influential biochemical research on alcohol-related liver injury, including solubilizing and isolating the microsomal ethanol-oxidizing system and exploring cytochrome P450–related pathways. This work strengthened his commitment to uncovering the biological foundations of hepatotoxicity and decisively shaped his future research direction. Returning to Germany, Professor Teschke continued to advance academically in gastroenterology, hepatology, and infectious diseases at the Heinrich Heine University of Düsseldorf. He completed his habilitation, received a prestigious university research award, and expanded his clinical and experimental work on alcohol-induced liver damage, hydrocarbon toxicity, and the growing challenge of drug-induced liver injury. As a department director at a major teaching hospital, he further deepened his focus on drug-induced liver injury, contributing significantly to the development and refinement of the RUCAM causality assessment method in collaboration with international experts. His scholarly output is substantial, consisting of more than 250 English-language publications, including books and book chapters. His work has earned 6,890 citations across 4,042 documents, with an h-index of 48, reflecting his strong influence in the global hepatology community. He has served as associate editor of Annals of Hepatology and held editorial roles across numerous leading medical and scientific journals.

Profile; Scopus | Orcid | Research Gate

Featured Publications:

Teschke, R. Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity. Review.
Annotation: Discusses two-step autoimmune hepatitis triggered by pharmaceutical agents, highlighting diagnostic and clinical implications.

Teschke, R. Acute Liver Failure with Determinate rather than Indeterminate Etiology Facilitates Therapy and May Avoid Liver Transplantation: A Critical Analysis. Review.
Annotation: Evaluates clinical outcomes in acute liver failure and argues the benefits of precise etiological identification.

Teschke, R., et al. Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic Algorithms. Review.
Annotation: Compares two validated diagnostic algorithms to strengthen causality assessment in drug-induced autoimmune hepatitis.

Teschke, R. Immunology Highlights of Four Major Idiosyncratic DILI Subtypes Verified by the RUCAM: A New Evidence-Based Classification. Review.
Annotation: Proposes an evidence-based immunological classification for idiosyncratic drug-induced liver injury (DILI).

Teschke, R., et al. Metabolic Mysteries of Copper Dysregulation in Wilson Disease. Review.
Annotation: Explores metabolic pathways and unresolved mechanisms underlying copper dysregulation in Wilson’s disease.

Teschke, R., et al. Open Questions on How Metabolic Dysfunction-Associated Steatotic Liver Disease Shapes the Course of Drug-Induced Liver Injury. Letter.
Annotation: Raises key unresolved scientific and clinical questions on the interaction between MASLD and DILI.

Ahsan Khan | Biomedical Engineering | Research Excellence Award

Published on by Scientist Day

Dr. Ahsan Khan | Biomedical Engineering | Research Excellence Award

Dr. Ahsan Khan | Tongji University | China

Dr. Ahsan Riaz Khan is an accomplished researcher specializing in chemical engineering, environmental sciences, corrosion science, surface engineering, and biomaterials. He holds advanced academic qualifications in Chemical Engineering and Environmental Sciences, complemented by strong interdisciplinary training across materials development, environmental health, and biomedical applications. He is currently serving as a Postdoctoral Researcher at the School of Medicine, Tongji University, Shanghai, where he contributes to cutting-edge research on biomaterials, corrosion-resistant surfaces, biocompatibility, drug-release systems, and in-vivo/in-vitro implant evaluations. Dr. Khan’s research expertise spans the development of novel, sustainable, and cost-effective coating materials; surface modification of metals and alloys; tribology; anticorrosion technology; adhesion engineering; electrochemical methods; and advanced techniques in cell culture, toxicity analysis, and immunohistochemistry. His interdisciplinary background enables him to work at the intersection of engineering, materials science, medicine, and environmental sustainability. He has published 28 peer-reviewed research papers, contributing significantly to high-impact journals in materials science, corrosion protection, biomaterials, environmental pollution, electrochemistry, and regenerative medicine. His publications have received over 330 citations with an H-index above 10, reflecting strong academic influence and global research engagement. His work includes notable contributions to magnesium alloys, smart scaffolds, hybrid biomaterials, environmental risk assessments, supercapacitive materials, and psychological health investigations. Dr. Khan has earned multiple academic honors, including innovation awards, competitive scholarships, excellence certificates, and internship recognitions. He has participated in a wide range of international conferences, workshops, and training programs in environmental management, materials engineering, GIS, chemical engineering, and waste management. Skilled in a broad array of analytical and characterization techniques—such as SEM, TEM, XPS, XRD, TGA, ICP-OES, GC-MS, Raman spectroscopy, and electrochemical workstations—Dr. Khan combines technical depth with strong research leadership. Fluent in English, Urdu, and conversational Chinese (HSK-3), he remains committed to advancing global research in materials innovation, corrosion engineering, environmental sustainability, and biomedical technology.

Profile: Google Scholar

Featured Publications

Khan, A. R., Grewal, N. S., Zhou, C., Yuan, K., Zhang, H. J., & Jun, Z. Recent advances in biodegradable metals for implant applications: Exploring in vivo and in vitro responses. Results in Engineering, 20, 101526.

Zafar, Z., Mehmood, M. S., Ahamad, M. I., Chudhary, A., Abbas, N., Khan, A. R., … Trend analysis of the decadal variations of water bodies and land use/land cover through MODIS imagery: An in-depth study from Gilgit-Baltistan, Pakistan. Water Supply, 21(2), 927–940.

Rehman, A. U., Shah, M. Z., Ali, A., Zhao, T., Shah, R., Ullah, I., Bilal, H., Khan, A. R., … Thermochemical heat storage ability of ZnSO₄·7H₂O as potential long-term heat storage material. International Journal of Energy Research, 45(3), 4746–4754.

Khan, M., Tiehu, L., Hussain, A., Raza, A., Zada, A., Alei, D., Khan, A. R., Ali, R., … Physiochemical evaluations, mechanical attenuations and thermal stability of graphene nanosheets and functionalized nanodiamonds loaded pitch-derived carbon foam composites. Diamond and Related Materials, 126, 109077.

Khan, Z. U., Razzaq, A., Khan, A., Rehman, N. U., Khan, H., Khan, T., Khan, A. U., … Physicochemical characterizations and pharmacokinetic evaluation of pentazocine solid lipid nanoparticles against inflammatory pain model. Pharmaceutics, 14(2), 409.

Sylvia Mangani | Medical Discoveries | Best Researcher Award

Published on by Scientist Day

Ms. Sylvia Mangani | Medical Discoveries | Best Researcher Award

Ms. Sylvia Mangani | University of Patras | Greece

Sylvia Mangani is a biochemist–biotechnologist and PhD candidate in Biochemistry at the University of Patras, whose research centers on cancer biology, particularly the influence of the extracellular matrix on tumor growth and regulation through 3D cell culture systems. Her academic journey combines strong foundations in biochemistry and biotechnology (BSc, MSc) with advanced experimental and analytical expertise. Her work integrates a broad range of molecular and cellular biology techniques, including quantitative PCR, Western blotting, immunofluorescence, functional assays, and RNA sequencing, complemented by bioinformatics analysis for gene expression and signaling pathway interpretation. Her research has significantly contributed to understanding how 3D cellular microenvironments influence cancer progression, focusing on breast cancer models. She has authored 12 peer-reviewed publications in recognized international journals, with her work cited over 55 times according to Google Scholar, reflecting growing recognition within the scientific community. Her contributions have also supported award-winning synthetic biology initiatives under the iGEM program and have been presented at national and international scientific conferences. She has established productive collaborations with prominent research institutions in Greece and abroad. Notably, she completed a funded Erasmus+ research placement at the University Hospital of Münster, Germany, under the supervision of Prof. Martin Götte, where she engaged in experimental oncology projects exploring cancer cell behavior and matrix interactions. She has also collaborated with the National and Kapodistrian University of Athens on biochemical and molecular analyses within the Laboratory of Biochemistry, Biotechnology, and Molecular Analysis. A member of the Hellenic Society of Biochemistry and Molecular Biology (HSBMB), she actively contributes to the advancement of biochemical and cancer research in Greece and Europe. Her ongoing studies aim to deepen the understanding of tumor–matrix dynamics in breast cancer, offering new insights for therapeutic innovation and cancer model development, positioning her among emerging researchers in molecular oncology.

Profiles: Orcid | Google Scholar | LinkedIn | Research Gate

Featured Publications 

Mangani, S., Piperigkou, Z., Mangani, S., Koletsis, N. E., Koutsakis, C., Mastronikolis, N. S., Franchi, M., & Karamanos, N. K. (2025, August). Principal mechanisms of extracellular matrix‐mediated cell–cell communication in physiological and tumor microenvironments. The FEBS Journal. https://doi.org/10.1111/febs.70207

Mangani, S., Vetoulas, M., Mineschou, K., Spanopoulos, K., Vivanco, M. d. M., Piperigkou, Z., & Karamanos, N. K. (2025, July 15). Design and applications of extracellular matrix scaffolds in tissue engineering and regeneration. Cells, 14(14), 1076. https://doi.org/10.3390/cells14141076

Franchi, M., Masola, V., Onisto, M., Franchi, L., Mangani, S., Zolota, V., Piperigkou, Z., & Karamanos, N. K. (2025, July 7). Ultrastructural changes of the peri-tumoral collagen fibers and fibrils array in different stages of mammary cancer progression. Cells, 14(13), 1037. https://doi.org/10.3390/cells14131037

Karamanos, N. K., Piperigkou, Z., Gourdoupi, C., Mangani, S., & Vivanco, M. d. M. (2025, June 1). Extracellular matrix matters: Matrix-based bioscaffolds in advancing translational cancer research and targeted therapy. American Journal of Physiology-Cell Physiology, 328(6), C1235–C1251. https://doi.org/10.1152/ajpcell.00050.2025

Ciampelli, C., Mangani, S., Nieddu, G., Formato, M., Ioannou, P., Kremmydas, S., Karamanos, N., & Lepedda, A. J. (2025, March). Effects of acidic polysaccharide-enriched extracts from Holothuria tubulosa on two- and three-dimensional invasive breast cancer cell models. Biology, 14(4), 334. https://doi.org/10.3390/biology14040334

Mangani, S., Kremmydas, S., & Karamanos, N. K. (2025, March). Mimicking the complexity of solid tumors: How spheroids could advance cancer preclinical transformative approaches. Cancers, 17(7), 1161. https://doi.org/10.3390/cancers17071161

Iffat Prianka | Public Health | Best Researcher Award

Published on by Scientist Day

Assist. Prof. Dr. Iffat Prianka | Public Health | Best Researcher Award

Assist. Prof. Dr. Iffat Prianka | Ibrahim Medical College | Bangladesh

Dr. Iffat Tania Prianka is an accomplished public health researcher and academic with extensive experience in community medicine, preventive and social medicine, and epidemiology. She holds an M. Phil. in Preventive and Social Medicine and an MPH in Epidemiology, and is currently pursuing a PhD. Her academic contributions include research on autism awareness among medical students, internet addiction, physical exercise practices among diabetic patients, and mental stress in infertile women. Dr. Prianka has served in diverse roles including Lecturer and Assistant Professor at Ibrahim Medical College, Senior House Physician at United Hospital Dhaka, and Lead Medical Officer and Public Health Expert at Fera Foundation, USA. She has significant experience in research methodology, data analysis, manuscript preparation, and public health program implementation. Her professional development includes international training in medical education, research methodology, data interpretation, and faculty development programs. She has presented at international conferences, received awards for academic excellence, and published multiple peer-reviewed research articles in reputable journals. Dr. Prianka is proficient in statistical software (SPSS, STATA) and skilled in scientific communication, teaching, and community health research.

Profile: Orcid

Featured Publications

Prianka, I. T., Haque, W., Jahan, N., Saha, M., Prity, T. T., & Gupta, P. K. S. (2022). Knowledge and attitude on early sign of autism among 1st year to 3rd year medical students in a selected medical college in Bangladesh. International Journal of Medical Research and Pharmaceuticals, 9(9).

Jahan, N., Idris, M. R., Prianka, I. T., & Gupta, P. K. S. (2022). Internet addiction and its determinants among medical students in Dhaka City during COVID-19 pandemic. International Journal of Medical Research and Pharmaceuticals, 9(12).